Vaxart, Inc. (VXRT)
OTCMKTS
· Delayed Price · Currency is USD
0.755
-0.025 (-3.21%)
Apr 28, 2026, 3:59 PM EST
Vaxart Employees
Vaxart had 65 employees as of December 31, 2025. The number of employees decreased by 40 or -38.10% compared to the previous year.
Employees
65
Change (1Y)
-40
Growth (1Y)
-38.10%
Revenue / Employee
$3,650,123
Profits / Employee
$251,185
Market Cap
187.80M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 88 |
| CytoDyn | 13 |
| Nuo Therapeutics | 10 |
| Cell Source | 1 |
| Vicapsys Life Sciences | 2 |
| Harvard Apparatus Regenerative Technology | 8 |
Vaxart News
- 5 days ago - Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors - GlobeNewsWire
- 11 days ago - Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital - GlobeNewsWire
- 6 weeks ago - Vaxart Transcript: Fireside chat - Transcripts
- 6 weeks ago - Vaxart Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Vaxart to Host Upcoming Conference Calls - GlobeNewsWire
- 2 months ago - Vaxart Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts
- 3 months ago - Vaxart Transcript: Global BioInnovation Forum 2026 - Transcripts
- 3 months ago - Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026 - GlobeNewsWire